Considering that only a fraction of beta cells would be preserved at T1D onset makes it important to intervene with GAD-alum immune tolerance treatment before T1D diagnosis at stages 1 and 2 in T1D progression to preserve beta cell function or delay onset by halting the T-cell mediated autoimmune process. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.